핵산 증폭 검사 시장 : 유형별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

The Nucleic Acid Amplification testing Market size was valued at US$9,897.45 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Nucleic Acid Amplification Testing market is experiencing robust global growth driven by the rising prevalence of infectious diseases worldwide and continuous technological advancements in molecular diagnostics. NAAT, a highly sensitive technique, is the gold standard for detecting and quantifying nucleic acids (DNA or RNA) and is vital in diagnosing conditions such as COVID-19, HIV, and Tuberculosis. The growing demand for rapid, decentralized Point-of-Care (POC) testing and the increasing application of NAAT in oncology and personalized medicine are key factors propelling market expansion.

Nucleic Acid Amplification testing Market- Market Dynamics

Rising Prevalence of Infectious Diseases and Public Health Crises

The rising prevalence of infectious diseases, including respiratory infections, sexually transmitted infections (STIs), and newly emerging or re-emerging pathogens, presents significant challenges for global public health systems, driven by factors such as globalization, urbanization, and climate change, For instance, according to the World Health Organization (WHO), approximately 10.8 million people were reported to have fallen ill with Tuberculosis (TB) globally in 2023, encompassing 6.0 million men, 3.6 million women, and 1.3 million children . In response, the adoption of Nucleic Acid Amplification Tests (NAAT) has become essential, primarily due to its high sensitivity and specificity, which facilitate early detection of infections even before symptoms appear. This early identification enables timely treatment, effectively minimizing adverse health outcomes and transmission rates, especially in the case of STIs. Moreover, NAAT plays a crucial role in public health surveillance, allowing for rapid testing during outbreaks and thereby aiding in the control of disease spread. Its adaptability to detect new pathogens is vital for responding to public health emergencies, underscoring the need for integrating NAAT into routine health strategies to enhance preparedness and resource allocation in combating infectious diseases.

Nucleic Acid Amplification testing Market- Segmentation Analysis:

The Global Nucleic Acid Amplification testing Market is segmented on the basis of Type, Application, End-use, and Region.

Based on Type, the market is divided into Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, and Others. PCR tests hold the largest share due to their high sensitivity, versatility, and widespread use in diagnostic and research applications, while INAAT tests are gaining traction for their rapid processing and suitability for point-of-care testing.

Based on Application, the market is divided into Infectious Disease Testing, Oncology Testing, Genetic & Mitochondrial Disease Testing, and Other Applications. Infectious disease testing accounts for the largest market share due to the rising prevalence of viral and bacterial infections, increasing demand for accurate diagnostic solutions, and widespread adoption of molecular testing in clinical laboratories.

Based on end use the market is divided into Central and Reference Laboratories, Point-of-Care Settings, Biotechnology & Pharmaceutical Companies, and Academic & Research Institutes and others. Central and reference laboratories account for a significant share due to their extensive testing services and commitment to accuracy and reliability in diagnostics. Point-of-care settings are experiencing rapid growth as demand increases for immediate diagnostic solutions that facilitate prompt clinical decision-making, particularly in urgent and remote care environments.

Nucleic Acid Amplification testing Market- Geographical Insights

The Nucleic Acid Amplification Testing market is predominantly driven by North America, which holds the largest share due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of infectious diseases. Following North America, the Asia Pacific region is experiencing substantial growth, propelled by rising healthcare expenditures, increasing demand for accurate diagnostic solutions, and a growing population with diverse health challenges. Europe ranks next, benefiting from robust healthcare systems and strong regulatory support for molecular diagnostics. Latin America (LATAM) is also witnessing growth, although at a slower pace, as improvements in healthcare access and rising awareness of infectious diseases contribute to the market's expansion. Lastly, the Middle East and Africa (MEA) region faces challenges such as limited healthcare resources, but efforts to enhance healthcare infrastructure and increasing disease awareness are gradually fostering market growth. Overall, the global distribution reflects varying levels of healthcare maturity and investment in diagnostic technologies.

Nucleic Acid Amplification testing Market- Country Insights

The United States is the dominant market for Nucleic Acid Amplification Testing (NAAT), driven by its advanced healthcare infrastructure, significant investment in research and development, and a high incidence of infectious diseases. The demand for accurate and rapid diagnostic solutions has fostered widespread adoption of NAAT across clinical laboratories, hospitals, and point-of-care settings. Additionally, the U.S. benefits from a strong regulatory framework that supports innovative diagnostic technologies. Other notable markets include Canada and Mexico, which are also experiencing growth due to increasing healthcare expenditures and rising awareness of molecular diagnostics, contributing to a robust North American market landscape.

Nucleic Acid Amplification testing Market- Competitive Landscape:

The Nucleic Acid Amplification Testing (NAAT) market is highly competitive, featuring key players like Roche, Abbott Laboratories, and Thermo Fisher Scientific, known for their innovative diagnostic solutions and extensive product portfolios. bioMerieux and Hologic focus on infectious disease testing, enhancing their market presence through advanced technologies and strategic partnerships. QIAGEN and Bio-Rad Laboratories emphasize assay development and molecular diagnostics, while Danaher leverages its strong R&D capabilities to drive growth. Grifols S.A. and Seegene Inc. are also making strides in the market, contributing unique technologies and expanding their geographical reach, thereby intensifying competition and fostering innovation in NAAT applications. These companies emphasize technological innovation, expansion of product portfolios, and strategic partnerships to enhance their global footprint. For instance, In July 2025, South Korea-based Seegene Inc. launched its CURECA fully automated PCR testing system alongside its STAgora data analytics platform. CURECA is notable as the world's first system to completely automate the entire PCR testing process, which includes everything from sample storage and pre-treatment to nucleic acid extraction, amplification, and final result analysis, requiring no human intervention. Seegene states that the introduction of these new technologies represents a transformative shift in the global diagnostics paradigm.

Recent Developments:

In September 2024 Takara Bio USA, Inc. introduced the SmartChip ND Real-Time PCR System, an automated, high-throughput quantitative PCR (qPCR) solution designated for research-use-only (RUO). This system is designed specifically for monitoring antimicrobial resistance (AMR), addressing the increasing global need for advanced tools in environmental safety and sustainability research.

In December 2025 Roche introduced the cobas BV/CV Assay, a new PCR-based diagnostic test that has received the CE Mark for use in accepting countries. This assay is designed to streamline the diagnostic workflow for vaginitis by utilizing a single vaginal swab to rapidly and accurately detect the bacteria responsible for bacterial vaginosis and the yeast associated with candida vaginitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Roche (F. Hoffmann-La Roche Ltd.)
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• bioMerieux
• Hologic
• QIAGEN
• Bio-Rad Laboratories
• Danaher
• Grifols S.A.
• Seegene Inc.
• Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

• Polymerase Chain Reaction (PCR) Tests
• Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
• Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

• Infectious Disease Testing
• Oncology Testing
• Genetic & Mitochondrial Disease Testing
• Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

• Central and Reference Laboratories
• Point-of-Care Settings
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Nucleic Acid Amplification Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Nucleic Acid Amplification Testing Market Snippet by Type
  • 2.1.2. Nucleic Acid Amplification Testing Market Snippet by Application
  • 2.1.3. Nucleic Acid Amplification Testing Market Snippet by End-use
  • 2.1.4. Nucleic Acid Amplification Testing Market Snippet by Country
  • 2.1.5. Nucleic Acid Amplification Testing Market Snippet by Region
• 2.2. Competitive Insights

3. Nucleic Acid Amplification Testing Key Market Trends

• 3.1. Nucleic Acid Amplification Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Nucleic Acid Amplification Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Nucleic Acid Amplification Testing Market Opportunities
• 3.4. Nucleic Acid Amplification Testing Market Future Trends

4. Nucleic Acid Amplification Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Nucleic Acid Amplification Testing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Nucleic Acid Amplification Testing Market Landscape

• 6.1. Nucleic Acid Amplification Testing Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Amplification Testing Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
  • 7.1.2. Polymerase Chain Reaction (PCR) Tests
  • 7.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • 7.1.4. Others

8. Nucleic Acid Amplification Testing Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
  • 8.1.2. Infectious Disease Testing
  • 8.1.3. Oncology Testing
  • 8.1.4. Genetic & Mitochondrial Disease Testing
  • 8.1.5. Others

9. Nucleic Acid Amplification Testing Market - By End-use

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
  • 9.1.2. Infectious Disease Testing
  • 9.1.3. Oncology Testing
  • 9.1.4. Genetic & Mitochondrial Disease Testing
  • 9.1.5. Others

10. Nucleic Acid Amplification Testing Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Nucleic Acid Amplification Testing Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Nucleic Acid Amplification Testing Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Nucleic Acid Amplification TestingKey Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Nucleic Acid Amplification Testing Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Nucleic Acid Amplification TestingKey Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
  • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
  • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
  • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Nucleic Acid Amplification Testing Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Roche (F. Hoffmann-La Roche Ltd.)
  • 11.2.2. Abbott Laboratories
  • 11.2.3. Thermo Fisher Scientific Inc.
  • 11.2.4. bioMerieux
  • 11.2.5. Hologic
  • 11.2.6. QIAGEN
  • 11.2.7. Bio-Rad Laboratories
  • 11.2.8. Danaher
  • 11.2.9. Grifols S.A.
  • 11.2.10. Seegene Inc.
  • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us